The Food and Drug Administration will not tolerate companies peddling marijuana-based products to treat cancer—at least, not without better evidence.
The agency sent four warning letters on Tuesday to companies selling products online with health claims about cancer, including that the products could stop tumors from growing. Products that were being sold include cannabidiol (CBD) oil, capsules, and edibles, among other things.
CBD is not the compound associated with marijuana’s high—that psychoactive compound is a different chemical, abbreviated THC.
“We have an obligation to provide caregivers and patients with the confidence that drugs making cancer treatment claims have been carefully evaluated for safety, efficacy, and quality, and are monitored by the FDA once they’re on the market,” FDA Commissioner Scott Gottlieb stated in a press release. “We support sound, scientifically-based research using components derived from marijuana, and we’ll continue